Cornea Editor Julie Schallhorn, MD, shared the topics covered in this section and her thoughts on the factors to consider with advancements, such as that of benefit to the patient vs. cost to the patient and the system.
Before giving readers a preview of the articles in the Cornea section, Julie Schallhorn, MD, shared a recent experience with AI that got her thinking about the field of ophthalmology. “Tools that once demanded specialized training are now within reach of any curious user,” she said.
“As we advance in medicine, the next frontier will be getting a true picture of the state of the patient—genetics, environment, and lifestyle—and using this to find the correct diagnosis and treatment,” said Julie Schallhorn, MD, as she introduced the articles in the Cornea section of the issue.
“To take something known and look at it from a new direction, to question our view of reality, to wonder, these are the strengths of children, but also of innovators,” said Julie Schallhorn, MD, introducing and commenting on the articles in the Cornea section of this issue.
Cornea Editor Julie Schallhorn, MD, shared her thoughts on the diagnosis and treatment of ocular surface disease, “one of the most vexing issues in ophthalmology.”
Cornea Editor Julie Schallhorn, MD, shared the story of a personal friend of hers to introduce the “must-read” article on corneal side effects of cancer-specific therapies, also mentioning the articles on Sjogren’s disease and pinhole apertures in the management of irregular corneas.
Cornea Editor Julie Schallhorn, MD, gave a preview of the articles in the section and talked about the current climate for institutional funding for research.
“The articles in this issue’s Cornea section focus on challenging situations in cornea and the tools that we have to address them,” said Cornea Editor Julie Schallhorn, MD. She expressed her frustration with the current healthcare environment in meeting the needs of these more challenging patients.
Julie Schallhorn, MD, shared the topics covered in the Cornea section, specifically noting that while she is excited for cultured endothelial cell therapies, she will “remember the ingenuity that went into the development of endothelial keratoplasty and the supreme teaching and innovation that made it a procedure adopted worldwide.”
In her introduction to the Cornea section, Julie Schallhorn, MD, pointed out that more and more, physicians are turning to chat groups and listservs when they face a hurdle. “I challenge our readers to think critically about the experiences and the anecdotes they encounter on listservs, chat groups, and social media,” she wrote.
Get the latest ophthalmology news delivered to your inbox every Friday.